Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (11-20 of 3,133) with videos related to

Pageof 314
Sort By:
Cytotherapy|June 12, 2016
Putting a price tag on novel autologous cellular therapiesMohamed Abou-El-Enein, Gerhard Bauer, Nicholas Medcalf, et al.
Cytotherapy|June 12, 2016
Allogeneic chondrogenically differentiated human mesenchymal stromal cells do not induce immunogenic responses from T lymphocytes in vitroCaoimhe H Kiernan, Martin J Hoogduijn, Marcella Franquesa, et al.
Cytotherapy|August 16, 2015
Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugsJohn Girdlestone, Jeffrey Pido-Lopez, Saket Srivastava, et al.
Cytotherapy|August 16, 2015
BMP4 inhibits myogenic differentiation of bone marrow-derived mesenchymal stromal cells in mdx miceCao Jiqing, Li Yaqin, Liang Yingyin, et al.
Cytotherapy|May 24, 2012
Interleukin-13 receptor α2: glioma's unlucky receptor?Stephen Gottschalk
Cytotherapy|December 25, 2014
Effect of mild heat stress on the proliferative and differentiative ability of human mesenchymal stromal cellsMahmood S Choudhery, Michael Badowski, Angela Muise, et al.
Cytotherapy|December 25, 2014
Human peripheral blood CD34+ cells attenuate oleic acid-induced acute lung injury in ratsSomia H Abd-Allah, Sally M Shalaby, Eman Abd-Elbary, et al.
Cytotherapy|July 6, 2014
Neurotrophic and neuroprotective potential of human limbus-derived mesenchymal stromal cellsChang-Min Liang, Shao-Ju Weng, Tung-Han Tsai, et al.
Cytotherapy|July 8, 2014
Mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in amyotrophic lateral sclerosisPeter Connick, Siddharthan Chandran
Cytotherapy|September 6, 2015
A phase I/II trial of interleukin-15--stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumorsAntonio Pérez-Martínez, Lucía Fernández, Jaime Valentín, et al.
Pageof 314

Showing results (11-20 of 3,133) with videos related to

Sort By:
Pageof 314
Cytotherapy|June 12, 2016
Putting a price tag on novel autologous cellular therapiesMohamed Abou-El-Enein, Gerhard Bauer, Nicholas Medcalf, et al.
Cytotherapy|June 12, 2016
Allogeneic chondrogenically differentiated human mesenchymal stromal cells do not induce immunogenic responses from T lymphocytes in vitroCaoimhe H Kiernan, Martin J Hoogduijn, Marcella Franquesa, et al.
Cytotherapy|August 16, 2015
Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugsJohn Girdlestone, Jeffrey Pido-Lopez, Saket Srivastava, et al.
Cytotherapy|August 16, 2015
BMP4 inhibits myogenic differentiation of bone marrow-derived mesenchymal stromal cells in mdx miceCao Jiqing, Li Yaqin, Liang Yingyin, et al.
Cytotherapy|May 24, 2012
Interleukin-13 receptor α2: glioma's unlucky receptor?Stephen Gottschalk
Cytotherapy|December 25, 2014
Effect of mild heat stress on the proliferative and differentiative ability of human mesenchymal stromal cellsMahmood S Choudhery, Michael Badowski, Angela Muise, et al.
Cytotherapy|December 25, 2014
Human peripheral blood CD34+ cells attenuate oleic acid-induced acute lung injury in ratsSomia H Abd-Allah, Sally M Shalaby, Eman Abd-Elbary, et al.
Cytotherapy|July 6, 2014
Neurotrophic and neuroprotective potential of human limbus-derived mesenchymal stromal cellsChang-Min Liang, Shao-Ju Weng, Tung-Han Tsai, et al.
Cytotherapy|July 8, 2014
Mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in amyotrophic lateral sclerosisPeter Connick, Siddharthan Chandran
Cytotherapy|September 6, 2015
A phase I/II trial of interleukin-15--stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumorsAntonio Pérez-Martínez, Lucía Fernández, Jaime Valentín, et al.
Pageof 314